Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Tepmetko Tablet:
Tepmetko 225mg Tablet is indicated for the treatment of advanced non-small cell lung cancer (NSCLC) in adult patients. It is specifically prescribed for individuals whose cancer has either metastasized to other areas of the body or cannot be surgically removed, and prior treatments have proven ineffective in halting disease progression.
Tepmetko 225mg Tablet functions by impeding the growth of cancer cells, thereby slowing down or arresting their proliferation. It is recommended to be taken with food and swallowed whole; crushing or chewing the tablet should be avoided. The dosage and duration of treatment are tailored to individual patient needs and response, and adherence to the prescribed regimen is crucial. While it may take some time to observe the benefits, it's essential not to discontinue the medication unless directed by your healthcare provider.
Uses of Tepmetko Tablet:
Treatment of Non-small cell lung cancer
Benefits of Tepmetko Tablet:
Treatment of Non-small cell lung cancer: Tepmetko 225mg Tablet is effective in managing a specific type of non-small cell lung cancer that has metastasized to other parts of the body in adults.
Mechanism of Action of Tepmetko Tablet:
Tepmetko 225mg Tablet operates by obstructing the activity of certain aberrant proteins responsible for signaling cancer cells to proliferate. This inhibition serves to decelerate or halt the dissemination of cancer cells within the body.